8-K - Silo Pharma, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Silo Pharma, Inc. acquired the QwikAgents web-based application software and associated domain names qwikagents.com, qwikagents.ai, and qwikagents.co from Many Ads Inc. in exchange for 2,100,000 shares of its common stock, marking a strategic expansion into AI-enabled agent technology.

Key Takeaways

1Silo Pharma acquired the 'QwikAgents' software and three domain names (qwikagents.com, qwikagents.ai, qwikagents.co) — a material asset purchase under Item 1.01.

2Consideration consisted solely of 2,100,000 unregistered shares of Silo Pharma common stock, par value $0.0001, issued to Many Ads Inc.

3The Agreement includes six-month survival of representations and warranties, with indemnification by the Seller for misrepresentations, third-party IP infringement, or gross negligence/fraud.

4The Seller warranted exclusive ownership of the Software and Domain Names, confirmed no pending or threatened IP disputes, and disclosed use of one LGPL-licensed optional dependency.

5Assignor agreed not to register or challenge any future 'qwikagents'-related domain names or trademarks, reinforcing Silo Pharma’s exclusive control over the brand.

Current Report Details

Event Type

Material Agreement

Securities Issuance

Exhibits On

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement.** On July 29, 2025, Silo Pharma, Inc. (the “Company”) entered into an asset purchase agreement (the “Agreement”) wit

Material Agreement

Source Document

3.02

Unregistered Sales of Equity Securities.** ** ** The information set forth under Item 1.01 is incorporated herein by reference. The offer and sale to the Seller

Securities Issuance

9.01

. Financial Statements and Exhibits.** (d) Exhibits. | Exhibit | | Description | |---|---|---| | 10.1 | | Asset Purchase Agreement, dated March 31, 2026, betwee

Exhibits Only

Transaction Details

Material Agreement

Agreement: Asset Purchase Agreement
Parties: Silo Pharma, Inc., Many Ads Inc.

•Effective Date: March 31, 2026
•Purchased Assets: Software comprising the entirety of the code for 'qwikagents.com' web-based application, including Source Code and Object Code; domain names qwikagents.com, qwikagents.ai, and qwikagents.co
•Purchase Price: 2,100,000 shares of Silo Pharma common stock, par value $0.0001 per share
•Representations and warranties survive for six months from Effective Date
•Seller indemnifies Buyer for misrepresentation, third-party IP infringement, or gross negligence/fraud
•Seller warrants exclusive ownership, no liens, no pending IP disputes, and full control over Software and Domain Names

Exhibits (2)

10.1

ASSET PURCHASE AGREEMENT, DATED MARCH 31, 2026, BETWEEN THE COMPANY AND MANY ADS INC

8-K

CURRENT REPORT